Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Locally Advanced Head-and-Neck Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT04325828
What this trial is testing

Apalutamide Combined With GnRH Agonist in Participants With Androgen Receptor Positive Salivary Gland Carcinoma

Who this might be right for
Salivary Gland Neoplasms
Janssen Pharmaceutical K.K. 31
Testing effectiveness (Phase 2)UnknownNCT05476965
What this trial is testing

Selected De-escalation Radiotherapy for Postoperative Head and Neck Squamous Cell Carcinoma

Who this might be right for
Head and Neck Squamous Cell CarcinomaRadiotherapyImmunotherapy+1 more
Hubei Cancer Hospital 20
Early research (Phase 1)Study completedNCT04091867
What this trial is testing

SEphB4-HSA With RT+Chemo or Cetux in Patients With Intermediate to High Risk LAHNSCC

Who this might be right for
Squamous Cell Carcinoma of Head and Neck
University of Colorado, Denver 3
Testing effectiveness (Phase 2)Study completedNCT00719550
What this trial is testing

AMG 102 Plus ECX for Unresectable Locally Advanced or Metastatic Gastric or Esophagogastric Junction Cancer

Who this might be right for
Esophagogastric Junction AdenocarcinomaGastric CancerEsophageal Cancer
Amgen 130
Testing effectiveness (Phase 2)UnknownNCT02762474
What this trial is testing

Trial of Concurrent Chemoradiotherapy for Locally Advanced Esophageal Cancer

Who this might be right for
Esophageal Cancer
Tianjin Medical University Cancer Institute and Hospital 30
Testing effectiveness (Phase 2)Study completedNCT01312350
What this trial is testing

Neoadjuvant Chemotherapy for Locally Advanced Squamous Cell Cancer of the Head and Neck (SCCHN)

Who this might be right for
Hypopharyngeal Cancer
Samsung Medical Center 40
Testing effectiveness (Phase 2)Study completedNCT03427359
What this trial is testing

Induction Cisplatin and Capecitabine Followed by Concurrent Chemoradiotherapy for Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
The University of Hong Kong-Shenzhen Hospital 65
Large-scale testing (Phase 3)Study completedNCT03099382
What this trial is testing

Study of SHR-1210 Versus Investigator's Choice of Chemotherapy for Participants With Advanced Esophageal Cancer

Who this might be right for
Esophageal Carcinoma
Jiangsu HengRui Medicine Co., Ltd. 457
Testing effectiveness (Phase 2)Looking for participantsNCT07039162
What this trial is testing

Study of Tislelizumab Combined With Chemoradiotherapy and Surgery for Unresectable Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma (ESCC)Locally Advanced Unresectable Esophageal Cancer
Ming-Yu Lien 45
Not applicableStudy completedNCT04098458
What this trial is testing

Navigation for Timely Adjuvant Therapy for Patients With Locally Advanced HNSCC

Who this might be right for
Squamous Cell Carcinoma of Head and Neck
Medical University of South Carolina 18
Testing effectiveness (Phase 2)Study completedNCT00910117
What this trial is testing

Induction Chemotherapy With Nimotuzumab in Locally Advanced Head and Neck Squamous Cell Carcinoma (HNSCC)

Who this might be right for
Head and Neck Cancer
Fudan University 40
Large-scale testing (Phase 3)Study completedNCT01348217
What this trial is testing

Radiochemotherapy With and Without Dose Escalation in Patients Presenting Locally Advanced or Inoperable Carcinoma of the Oesophagus

Who this might be right for
Esophageal Cancer
Centre Georges Francois Leclerc 196
Large-scale testing (Phase 3)Ended earlyNCT04459715
What this trial is testing

Xevinapant (Debio 1143) in Combination With Platinum-Based Chemotherapy and Standard Fractionation Intensity-Modulated Radiotherapy in Participants With Locally Advanced Squamous Cell Carcinoma of the Head and Neck, Suitable for Definitive Chemoradiotherapy (TrilynX)

Who this might be right for
Squamous Cell Carcinoma of the Head and Neck
EMD Serono Research & Development Institute, Inc. 730
Testing effectiveness (Phase 2)Study completedNCT00510640
What this trial is testing

Thyroid Cancer and Sunitinib

Who this might be right for
CancerThyroid Carcinoma
University Hospital, Bordeaux 71
Testing effectiveness (Phase 2)Ended earlyNCT01732640
What this trial is testing

A Phase I/II Study Afatinib/Carboplatin/Paclitaxel Induction Chemotherapy In HPV-Negative HNSCC.

Who this might be right for
Squamous Cell Carcinoma of the Head and Neck
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 9
Early research (Phase 1)Study completedNCT02964455
What this trial is testing

Study of Concurrent Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma
Sun Yat-sen University 12
Testing effectiveness (Phase 2)Looking for participantsNCT05937438
What this trial is testing

Postoperative Radiotherapy Followed by Immunotherapy for Locally Advanced Esophageal Carcinoma

Who this might be right for
Esophageal Carcinoma
Anhui Provincial Hospital 70
Large-scale testing (Phase 3)Active Not RecruitingNCT05152147
What this trial is testing

Zanidatamab in Combination With Chemotherapy Plus or Minus Tislelizumab in Patients With HER2-positive Advanced or Metastatic Gastric and Esophageal Cancers

Who this might be right for
Gastric NeoplasmsGastroesophageal AdenocarcinomaEsophageal Adenocarcinoma
Jazz Pharmaceuticals 920
Testing effectiveness (Phase 2)Study completedNCT01309633
What this trial is testing

Study Evaluating Two Loading Regimens of Sunitinib or Bevacizumab Alternating With Cisplatin and Gemcitabine as Induction Therapy for Locally Advanced Nasopharyngeal Carcinoma (NPC)

Who this might be right for
Nasopharyngeal Carcinoma
National University Hospital, Singapore 80
Testing effectiveness (Phase 2)Looking for participantsNCT07811752
What this trial is testing

Sacituzumab Govitecan Combined With Tislelizumab for Locally Advanced/Metastatic Esophageal Cancer

Who this might be right for
Esophageal Squamous Cell Carcinoma
Shanghai Chest Hospital 28
Next Page